In addition, HPS2 patients frequently present with neutropenia [78]; although resolution of neutropenia by treatment with granulocyte colony stimulating factor does not reduce the rate of bacterial infections, neutropenia might also be a consequence of reduced IL-17 production, which is required for granulopoiesis [79]. This evidence concerns the gene IL17A and bacterial infectious disease.